Re: Summary of ongoing and planned clinical trials

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10605 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Summary of ongoing and planned clinical trials

in response to

Summary of ongoing and planned clinical trials

BearDownAZ

posted on Dec 23, 2020 08:49PM

"Exciting potential for the National Cancer Institute (NCI) CRADA (cooperative research and development agreement) program to explore combination drug strategies."

In a nutshell, this surely removes any notion of a total sale of Zenith, seeing that CRADA would be developing strong partnerships with multinational pharmaceutical companies.